Together, we see a recurring pattern among patients using GLP-1 medications as they prepare for surgery: many attempt to protect their results by restricting food intake, when in reality, proper nourishment is one of the most powerful tools for healing and recovery
Diabetes 63 , 18291830 (2014)
Retatrutide, a GIP, GLP-1 and Glucagon Receptor Agonist, for People With Type 2 Diabetes: A Randomised, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Phase 2 Trial
The Medical Foundation: Why GLP-1 Medications Represent a Paradigm Shift According to medical literature and FDA approval documentation, GLP-1 receptor agonist medications represent the most significant pharmacological advancement in obesity medicine in decades
Stepping back, its clear that BED is a serious disease and clinicians who treat it have limited tools
Convenient: Self-administer once per week from the comfort of your home